🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Punnee Pitisuttithum

Mahidol University

ORCID: 0000-0003-3215-2183

Also affiliated with Mahidol Oxford Tropical Medicine Research Unit

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial”.

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101323
N/A
1.3DataRank · unranked
55 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +42 more

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(20)30694-0
N/A
0.584DataRank · unranked
48 citations

Humberto Reynales, Airi Poder, Charles Y Yu, Punnee Pitisuttithum, Lee Li Yuan +9 more

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

medRxiv(2021)10.1101/2021.09.17.21263758
N/A
0.486DataRank · unranked
8 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +41 more

HIV-1 Prophylactic Vaccine Trials in Thailand

Current HIV Research(2005)10.2174/1570162052772933
N/A
0.477DataRank · unranked
23 citations

Punnee Pitisuttithum

Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response

JCI Insight(2020)10.1172/jci.insight.135057
N/A
0.406DataRank · unranked
14 citations

Sally Shin, Carolyn M. Boudreau, Margaret E. Ackerman, Supachai Rerks‐Ngarm, Punnee Pitisuttithum +9 more

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

Emerging Microbes & Infections(2025)10.1080/22221751.2025.2485317
N/A
0.260DataRank · unranked
4 citations

Shuying Sue Li, Elena Giorgi, LaTonya D. Williams, One Dintwe, Lindsay N. Carpp +34 more

Accomplishments and challenges in developing improved influenza vaccines: An evaluation of three years of progress toward the milestones of the influenza vaccines research and development roadmap

Vaccine(2025)10.1016/j.vaccine.2025.127431
N/A
0DataRank · unranked
6 citations

Natalie Vestin, Angela J Mehr, Angela K. Ulrich, Lauren Bigalke, Joseph Bresee +35 more

HIV vaccine delayed boosting increases Env variable region 2–specific antibody effector functions

JCI Insight(2020)10.1172/jci.insight.131437
N/A
0DataRank · unranked
27 citations

Justin Pollara, Kan Luo, Benjamin M. Janus, Neelakshi Gohain, LaTonya D. Williams +38 more